BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21275464)

  • 1. Quantification of ZAP-70 expression in chronic lymphocytic leukemia: T/B-cell ratio of mean fluorescence intensity provides stronger prognostic value than percentage of positive cells.
    Smolej L; Vroblova V; Motyckova M; Jankovicova K; Schmitzova D; Krejsek J; Maly J
    Neoplasma; 2011; 58(2):140-5. PubMed ID: 21275464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia.
    Kern W; Dicker F; Schnittger S; Haferlach C; Haferlach T
    Cytometry B Clin Cytom; 2009 Nov; 76(6):385-93. PubMed ID: 19479984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of an easily applicable method of ZAP-70 measurement in chronic lymphocytic leukemia in the routine flow cytometry setting: A methodological approach.
    Passam F; Tachynopoulou V; Skoumi D; Tsompanakou A; Stavropoulos-Giokas A; Vadikolia C; Anagnostopoulos A; Paterakis G
    Ann Hematol; 2006 Nov; 85(11):795-805. PubMed ID: 16871389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.
    Rossi FM; Del Principe MI; Rossi D; Irno Consalvo M; Luciano F; Zucchetto A; Bulian P; Bomben R; Dal Bo M; Fangazio M; Benedetti D; Degan M; Gaidano G; Del Poeta G; Gattei V
    J Transl Med; 2010 Mar; 8():23. PubMed ID: 20211015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process.
    Letestu R; Rawstron A; Ghia P; Villamor N; Boeckx N; Boettcher S; Buhl AM; Duerig J; Ibbotson R; Kroeber A; Langerak A; Le Garff-Tavernier M; Mockridge I; Morilla A; Padmore R; Rassenti L; Ritgen M; Shehata M; Smolewski P; Staib P; Ticchioni M; Walker C; Ajchenbaum-Cymbalista F
    Cytometry B Clin Cytom; 2006 Jul; 70(4):309-14. PubMed ID: 16906588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a blocking antibody method for the flow cytometric measurement of ZAP-70 in B-CLL.
    Shenkin M; Maiese R
    Cytometry B Clin Cytom; 2006 Jul; 70(4):251-8. PubMed ID: 16906584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of zeta-associated protein (ZAP-70) and CD38 expression in chronic lymphocytic leukemia.
    el-Sharnouby JA; el-Shakankiri AA; Hendy OM; Ahmed LM; Taha AM
    Egypt J Immunol; 2006; 13(2):69-84. PubMed ID: 18689273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia.
    Sheridan R; Mounajjed T; Ehrmann DE; Hurtubise PE; Schrager JA
    Cytometry B Clin Cytom; 2006 Jul; 70(4):320-1. PubMed ID: 16906578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MFI ratio estimation of ZAP-70 in B-CLL by flow cytometry can be improved by considering the isotype-matched antibody signal.
    Marquez ME; Deglesne PA; Suarez G; Romano E
    Int J Lab Hematol; 2011 Apr; 33(2):194-200. PubMed ID: 20942870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZAP-70 by flow cytometry: a comparison of different antibodies, anticoagulants, and methods of analysis.
    Best OG; Ibbotson RE; Parker AE; Davis ZA; Orchard JA; Oscier DG
    Cytometry B Clin Cytom; 2006 Jul; 70(4):235-41. PubMed ID: 16906573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors].
    Xu W; Shen QD; Yu H; Qiao C; Wu YJ; Liu Q; Zhu DX; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):8-12. PubMed ID: 19563027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
    Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
    N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Significance of Combined Expression of ZAP-70 and CD38 in Chronic Lymphocytic Leukemia.
    Assem M; Abdel Hamid T; Kohla S; Arsanyos S
    J Egypt Natl Canc Inst; 2009 Dec; 21(4):287-97. PubMed ID: 21415865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients.
    Meuleman N; Stamatopoulos B; Dejeneffe M; El Housni H; Lagneaux L; Bron D
    Leukemia; 2008 Oct; 22(10):1882-90. PubMed ID: 18633433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry.
    Adams RL; Cheung C; Banh R; Saal R; Cross D; Gill D; Self M; Klein K; Mollee P
    Cytometry B Clin Cytom; 2014 Mar; 86(2):80-90. PubMed ID: 24127306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome.
    Kay S; Herishanu Y; Pick M; Rogowski O; Baron S; Naparstek E; Polliack A; Deutsch VR
    Cytometry B Clin Cytom; 2006 Jul; 70(4):218-26. PubMed ID: 16456869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
    Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL
    Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.